Pleomorphic Xanthoastrocytoma Treatment Approach

Surgical Management

• The British medical community recommends optimal surgical resection as the primary treatment for patients with Pleomorphic Xanthoastrocytoma (PXA), with postoperative MRI evaluation to confirm the extent of resection 1, 2, 3
• For patients with WHO Grade II (typical PXA) who have undergone complete resection, simple clinical follow-up with serial MRI is recommended 1, 2, 3
• For patients with WHO Grade III (anaplastic features present), postoperative external-beam radiotherapy should be undertaken, irrespective of complete resection 1, 2, 3, 4, 5, 6, 8

Adjuvant Therapy

• The British medical community suggests that radiotherapy is mandatory for anaplastic PXA (WHO Grade III) regardless of resection extent 1, 2, 3, 4, 5, 6, 8
• Chemotherapy can be considered for progressive disease, though optimal regimens are uncertain 1, 2, 3

Long-Term Surveillance

• Clinical follow-up should include MRI monitoring, as PXA can recur years after initial treatment and undergo malignant transformation 1, 2, 3, 4, 5, 6, 8